Accelerated sterility testing unlocks safe delivery of life-saving therapies

1. Rader, R. A. (Re)defining biopharmaceutical. Nat. Biotechnol. 26, 743–751 (2008). An article that defines the scope of biopharmaceuticals and their distinction from conventional, chemically synthesized drugs.

   Article  CAS  PubMed  Google Scholar 

2. Baker, D. J. et al. CAR T therapy beyond cancer: the evolution of a living drug. Nature 619, 707–715 (2023). An article presenting CAR T cells as a living therapeutic that eradicates refractory blood cancers and might also extend to non-cancer diseases.

   Article  CAS  PubMed  PubMed Central  Google Scholar 

3. Cundell, T., Atkins, J. W. & Lau, A. F. Sterility testing for hematopoietic stem cells. J. Clin. Microbiol. 61, e0165422 (2023). An article that reviews current sterility testing practices for haematopoietic stem cells and discusses strategies to enhance speed and safety in clinical applications.

   Article  PubMed  Google Scholar 

4. Kim, T. H. et al. Blood culture-free ultra-rapid antimicrobial susceptibility testing. Nature 632, 893–902 (2024). An article that presents a synthetic-peptide nanoparticle for rapid microbial detection in clinical diagnostics.

   Article  CAS  PubMed  Google Scholar 

Download references

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Kang, J. et al. One-day rapid sterility test for human-derived biopharmaceuticals. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-025-01524-3 (2025).